First trimester embryo-fetoscopic and ultrasound-guided fetal blood sampling for ex vivo viral transduction of cultured human fetal mesenchymal stem cells

Human Reproduction

Volumn 23, Issue 11, 2008, Pages 2427-2437

  Chan, Jerry ^a,b,c   Kumar, Sailesh ^a,b   Fisk, Nicholas M ^a,b,d  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b QUEEN CHARLOTTE S AND CHELSEA HOSPITAL   (United Kingdom)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Fetal blood sampling; Fetoscopy; Gene therapy; Mesenchymal stem cells; Percutaneous umbilical blood sampling

Indexed keywords

ADULT; ARTICLE; BRADYCARDIA; CELL ISOLATION; CELL RENEWAL; DIAGNOSTIC PROCEDURE; EMBRYO; EMBRYO FETOSCOPY; ENGRAFTMENT; EX VIVO STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; GENETIC DISORDER; GENETIC MANIPULATION; GESTATIONAL AGE; HUMAN; HUMAN CELL; LENTIVIRINAE; MESENCHYMAL STEM CELL; PREGNANCY TERMINATION; ULTRASOUND GUIDED FETAL BLOOD SAMPLING; VIRAL GENE DELIVERY SYSTEM;

EID: 54149104472     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/den302     Document Type: Article

References (52)

1. Aiuti A, Vai S, Mortellaro A, Casorati G, Ficara F, Andolfi G, Ferrari G, Tabucchi A, Carlucci F, Ochs HD et al. Immune reconstitution in ADA-SCID after PBL gene therapy and discontinuation of enzyme replacement. Nat Med 2002;8:423-425.
2. Amendola M, Venneri MA, Biffi A, Vigna E, Naldini L. Coordinate dual-gene transgenesis by lentiviral vectors carrying synthetic bidirectional promoters. Nat Biotechnol 2005;23:108-116.
3. Bigger BW, Siapati EK, Mistry A, Waddington SN, Nivsarkar MS, Jacobs L, Perrett R, Holder MV, Ridler C, Kemball-Cook G et al. Permanent partial phenotypic correction and tolerance in a mouse model of hemophilia B by stem cell gene delivery of human factor IX. Gene Ther 2006;13:117-126.
4. Brace RA. Blood volume and its measurement in the chronically catheterized sheep fetus. Am J Physiol 1983;244:H487-H494.
5. Brenner WE, Edelman DA, Hendricks CH. A standard of fetal growth for the United States of America. Am J Obstet Gynecol 1976;126:555-564.
6. Campagnoli C, Fisk N, Overton T, Bennett P, Watts T, Roberts I. Circulating hematopoietic progenitor cells in first trimester fetal blood. Blood 2000;95:1967-1972.
7. Campagnoli C, Roberts IA, Kumar S, Bennett PR, Bellantuono I, Fisk NM. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 2001;98:2396-2402.
8. Chan J, O'Donoghue K, de la Fuente J, Roberts IA, Kumar S, Morgan JE, Fisk NM. Human fetal mesenchymal stem cells as vehicles for gene delivery. Stem Cells 2005;23:93-102.
9. Chan J, O'Donoghue K, Gavina M, Torrente Y, Kennea N, Mehmet H, Stewart H, Watt DJ, Morgan JE, Fisk NM. Galectin-1 induces skeletal muscle differentiation in human fetal mesenchymal stem cells and increases muscle regeneration. Stem Cells 2006;24:1879-1891.
10. Chan J, Waddington SN, O'Donoghue K, Kurata H, Guillot PV, Gotherstrom C, Themis M, Morgan JE, Fisk NM. Widespread distribution and muscle differentiation of human fetal mesenchymal stem cells after intrauterine transplantation in dystrophic mdx mouse. Stem Cells 2007;25:875- 884.
11. Daffos F. Fetal blood sampling. Annu Rev Med 1989;40:319- 329.
12. De Coppi P, Bartsch G, Jr, Siddiqui MM, Xu T, Santos CC, Perin L, Mostoslavsky G, Serre AC, Snyder EY, Yoo JJ et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 2007;25:100-106.
13. Dejneka NS, Surace EM, Aleman TS, Cideciyan AV, Lyubarsky A, Savchenko A, Redmond TM, Tang W, Wei Z, Rex TS et al. In utero gene therapy rescues vision in a murine model of congenital blindness. Mol Ther 2004;9:182-188.
14. Flake AW. In utero stem cell transplantation. Best Pract Res Clin Obstet Gynaecol 2004;18:941-958.
15. Flake AW, Zanjani ED. In utero hematopoietic stem cell transplantation: ontogenic opportunities and biologic barriers. Blood 1999;94:2179- 2191.
16. Gaspar HB, Parsley KL, Howe S, King D, Gilmour KC, Sinclair J, Brouns G, Schmidt M, Von Kalle C, Barington T et al. Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector. Lancet 2004;364:2181-2187.
17. Goodnow CC. Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires. Proc Natl Acad Sci USA 1996;93:2264-2271.
18. Gotherstrom C, Ringden O, Westgren M, Tammik C, Le Blanc K. Immunomodulatory effects of human foetal liver-derived mesenchymal stem cells. Bone Marrow Transplant 2003;32:265-272.
19. Guillot PV, Abass O, Bassett JH, Shefelbine SJ, Bou-Gharios G, Chan J, Kurata H, Williams GR, Polak J, Fisk NM. Intrauterine transplantation of human fetal mesenchymal stem cells from first trimester blood repairs bone and reduces fractures in osteogenesis imperfecta mice. Blood 2008a;111:1717- 1725.
20. Guillot PV, Cook HT, Pusey CD, Fisk NM, Harten S, Moss J, Shore I, Bou-Bharios G. Transplantation of human fetal mesenchymal stem cells improves glomerulopathy in a collagen type Iα2-deficient mouse. J Pathol 2008b, in press.
21. Hacein-Bey-Abina S, Le Deist F, Carlier F, Bouneaud C, Hue C, De Villartay JP, Thrasher AJ, Wulffraat N, Sorensen R, Dupuis-Girod S et al. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med 2002;346:1185-1193.
22. Harrison DE, Zhong RK, Jordan CT, Lemischka IR, Astle CM. Relative to adult marrow, fetal liver repopulates nearly five times more effectively long-term than short-term. Exp Hematol 1997;25:293-297.
23. Hayashi S, Abdulmalik O, Peranteau WH, Ashizuka S, Campagnoli C, Chen Q, Horiuchi K, Asakura T, Flake AW. Mixed chimerism following in utero hematopoietic stem cell transplantation in murine models of hemoglobinopathy. Exp Hematol 2003;31:176-184.
24. Haynes BF. Phenotypic characterization and ontogeny of components of the human thymic microenvironment. Clin Res 1984;32:500-507.
25. Hobbins JC, Grannum PA, Romero R, Reece EA, Mahoney MJ. Percutaneous umbilical blood sampling. Am J Obstet Gynecol 1985;152:1-6.
26. Holyoake TL, Nicolini FE, Eaves CJ. Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrow. Exp Hematol 1999;27:1418-1427.
27. In't Anker PS, Noort WA, Scherjon SA, Kleijburg-van der Keur C, Kruisselbrink AB, van Bezooijen RL, Beekhuizen W, Willemze R, Kanhai HH, Fibbe WE. Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. Haematologica 2003a;88:845-852.
28. In't Anker PS, Scherjon SA, Kleijburg-van der Keur C, Noort WA, Claas FH, Willemze R, Fibbe WE, Kanhai HH. Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 2003b;102:1548-1549.
29. Kurata H, Guillot PV, Chan J, Fisk NM. Osterix induces osteogenic gene expression but not differentiation in primary human fetal mesenchymal stem cells. Tissue Eng 2007;13:1513-1523.
30. Lam YH, Tang MH. Prenatal diagnosis of haemoglobin Bart's disease by cordocentesis at 12-14 weeks-experience with the first 59 cases. Prenatal Diagnosis 2000;20:900-904.
31. Macdonald AA, Rose J, Heymann MA, Rudolph AM. Heart rate response of fetal and adult sheep to hemorrhage stress. Am J Physiol 1980;239:H789-H793.
32. Miliou-Paouleskou D, Antsaklis A, Papantoniou N, Koutra P, Daskalakis G. First trimester transabdominal embryo fetoscopy. Early Pregnancy 2001;5:36-37.
33. Muench MO. In utero transplantation: baby steps towards an effective therapy. Bone Marrow Transplant 2005;35:537-547.
34. Murdoch B, Gallacher L, Awaraji C, Hess DA, Keeney M, Jay K, Chadwick K, Fowley SR, Howson-Jan K, Chin YeeI et al. Circulating hematopoietic stem cells serve as novel targets for in utero gene therapy. FASEB J 2001;15:1628-1630.
35. Nicolaides KH, Clewell WH, Rodeck CH. Measurement of human fetoplacental blood volume in erythroblastosis fetalis. Am J Obstet Gynecol 1987;157:50-53.
36. Nicolini U, Santolaya J, Ojo OE, Fisk NM, Hubinont C, Tonge M, Rodeck CH. The fetal intrahepatic umbilical vein as an alternative to cord needling for prenatal diagnosis and therapy. Prenat Diagn 1988;8:665-671.
37. Orlandi F, Damiani G, Jakil C, Lauricella S, Bertolino O, Maggio A. The risks of early cordocentesis (12-21 weeks): analysis of 500 procedures. Prenat Diagn 1990;10:425-428.
38. Ott MG, Schmidt M, Schwarzwaelder K, Stein S, Siler U, Koehl U, Glimm H, Kuhlcke K, Schilz A, Kunkel H et al. Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat Med 2006;12: 401-409.
39. Polkinghorne J. Review of the Guidance on the Research Use of Fetuses and Fetal Material. CM 762. London: HMSO, 1989.
40. Rebel VI, Miller CL, Eaves CJ, Lansdorp PM. The repopulation potential of fetal liver hematopoietic stem cells in mice exceeds that of their liver adult bone marrow counterparts. Blood 1996;87:3500-3507.
41. Renda MC, Fecarotta E, Dieli F, Markling L, Westgren M, Damiani G, Jakil C, Picciotto F, Maggio A. Evidence of alloreactive T lymphocytes in fetal liver: implications for fetal hematopoietic stem cell transplantation. Bone Marrow Transplant 2000a;25:135-141.
42. Renda MC, Fecarotta E, Maggio A, Dieli F, Sireci G, Salerno A, Markling L, Westgren M, Dmiani G, Jakil C et al. In utero fetal liver hematopoietic stem cell transplantation: is there a role for alloreactive T lymphocytes. Blood 2000b;96:1608-1609.
43. Seppen J, van der Rijt R, Looije N, van Til NP, Lamers WH, Oude Elferink RP. Long-term correction of bilirubin UDPglucuronyltransferase deficiency in rats by in utero lentiviral gene transfer. Mol Ther 2003;8:593- 599.
44. Shannon C, Jauniaux E, Gulbis B, Thiry P, Sitham M, Bromley L. Placental transfer of fentanyl in early human pregnancy. Hum Reprod 1998;13: 2317-2320.
45. Shields LE, Lindton B, Andrews RG, Westgren M. Fetal hematopoietic stem cell transplantation: a challenge for the twenty-first century. J Hematother Stem Cell Res 2002;11:617-631.
46. Sprent J. Central tolerance of T cells. Int Rev Immunol 1995;13:95-105.
47. Surbek DV, Tercanli S, Holzgreve W. Transabdominal first trimester embryofetoscopy as a potential approach to early in utero stem cell transplantation and gene therapy. Ultrasound Obstet Gynecol 2000;15:302-307.
48. Surbek DV, Young A, Danzer E, Schoeberlein A, Dudler L, Holzgreve W. Ultrasound-guided stem cell sampling from the early ovine fetus for prenatal ex vivo gene therapy. Am J Obstet Gynecol 2002;187:960-963.
49. Taylor PA, McElmurry RT, Lees CJ, Harrison DE, Blazar BR. Allogenic fetal liver cells have a distinct competitive engraftment advantage over adult bone marrow cells when infused into fetal as compared with adult severe combined immunodeficient recipients. Blood 2002;99:1870-1872.
50. Tsai MS, Lee JL, Chang YJ, Hwang SM. Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Hum Reprod 2004;19:1450-1456.
51. Waddington SN, Nivsarkar MS, Mistry AR, Buckley SM, Kemball-Cook G, Mosley KL, Mitrophanous K, Radcliffe P, Holder MV, Brittan M et al. Permanent phenotypic correction of hemophilia B in immunocompetent mice by prenatal gene therapy. Blood 2004;104:2714-2721.
52. Weissman A, Jakobi P, Bronshtein M, Goldstein I. Sonographic measurements of the umbilical cord and vessels during normal pregnancies. J Ultrasound Med 1994;13:11-14.